Subscribe: Untitled
http://rss.prnewswire.com/geography/CO
Preview: Untitled

PR Newswire:



PR Newswire: All Press Releases



Published: Sat, 24 Jun 2017 15:14:59 EDT

Last Build Date: Sat, 24 Jun 2017 14:57:00 EDT

 



Deer Jet: ¿cuál será el siguiente destino del 787 Dream Jet?

Sat, 24 Jun 2017 14:57:00 EDT

PEKÍN, 24 de junio de 2017 /PRNewswire/ -- En el mes de septiembre de 2016, el mundialmente famoso 787 Dream Jet realizó su vuelo inaugural a Hong Kong y se unió a la flota de aviones gestionados por Deer Jet. Una vez en manos de Deer Jet, esta obra maestra de ingeniería humana y...



Art of Conquest macht weltweites Debut auf HiGame, internationale Spieler können Spiel zum ersten Mal erleben

Sat, 24 Jun 2017 13:23:00 EDT

PEKING, 24. Juni 2017 /PRNewswire/ -- Am 23. Juni 2017 hat Lilith Games sein Spiel Art of Conquest auf Huawei HiGame als weltweiten Release vorgestellt. Mit diesem Release können Spieler im Nahen Osten und in Südostasien das Spiel erleben und sich über exklusive In-Game-Geschenke...



Celosvetový debut hry Art of Conquest na HiGame dáva medzinárodným hráčom prvú možnosť vyskúšať si ju.

Sat, 24 Jun 2017 13:22:00 EDT

PEKING, 24. júna 2017 /PRNewswire/ -- Lilith Games uviedla 23. júna 2017 na celosvetový trh novú hru Art of Conquest v rámci Huawei HiGame. Toto vydanie hry si budú môcť vyskúšať hráči zo stredovýchodnej a juhovýchodnej Ázie a spolu s ním získať aj exkluzívne darčeky v rámci...



Deer Jet : Quelle est la prochaine destination du 787 Dream Jet ?

Sat, 24 Jun 2017 13:16:00 EDT

BEIJING, 24 juin 2017 /PRNewswire/ -- Le premier 787 Dream Jet du monde a fait son premier vol vers Hong Kong en septembre 2016 et a rejoint la flotte gérée par Deer Jet. Ce chef-d'œuvre humain d'ingénierie et de conception a été transformé en un objet d'art lorsqu'il a été placé...



This Is a Test From PR Newswire - MR

Sat, 24 Jun 2017 11:08:00 EDT

(image) CLEVELAND, June 24, 2016 /PRNewswire/ -- This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a...



Media Files:
https://mma.prnewswire.com/media/527392/PRN_Cision_logo40_Logo.jpg




J&W Reminds Investors of Deadline in Suit Filed against Synchronoss Technologies, Inc.; Should Officers and Directors be Responsible for the Alleged Harm?

Sat, 24 Jun 2017 10:48:00 EDT

(image) SAN DIEGO, June 24, 2017 /PRNewswire/ -- Johnson & Weaver, LLP reminds investors that a class action case was filed against Synchronoss Technologies, Inc. (NASDAQ: SNCR) ("Synchronoss") for purchasers of the stock between December 6, 2016 and April 26, 2017, inclusive (the "Class...



Media Files:
http://johnsonandweaver.com




This Is a Test From PR Newswire 4

Sat, 24 Jun 2017 10:30:00 EDT

CLEVELAND, June 24, 2017 /PRNewswire/ -- This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test...



Book on Ruined Footballer Was Top Seller at Amazon.com, Says the Portuguese Publisher Fronteira do Caos

Sat, 24 Jun 2017 08:00:00 EDT

(image) PORTO, Portugal, June 24, 2017 /PRNewswire/ -- The Portuguese publisher Fronteira do Caos claims the Kindle eBook The Rise and Fall of a Poor Man was #1 on Amazon.com in April and June. Written by John Rose, the book on a ruined footballer is inspired by true stories.     ...



Media Files:
http://mma.prnewswire.com/media/526188/The_Rise_and_Fall_of_a_Poor_Man.jpg




This Is a Test From PR Newswire 7

Sat, 24 Jun 2017 07:57:00 EDT

(image) CLEVELAND, June 24, 2017 /PRNewswire/ -- This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test...



Media Files:
https://mma.prnewswire.com/media/527389/gradient_test.jpg




HARMONY presenta los nuevos proyectos durante el 22nd Annual Congress de la European Hematology Association

Sat, 24 Jun 2017 07:38:00 EDT

(image) MADRID, June 24, 2017 /PRNewswire/ -- HARMONY: La red europea de excelencia en hematología y Big Data presenta los nuevos proyectos del laboratorio a la práctica durante el 22nd Annual Congress de la European Hematology Association Proporcionando el tratamiento...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




This Is a Test From PR Newswire 5

Sat, 24 Jun 2017 07:34:00 EDT

CLEVELAND, June 24, 2017 /PRNewswire/ -- This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test...



Мировой дебют Art of Conquest на HiGame даёт игрокам по всему миру возможность первыми испытать новую игру

Sat, 24 Jun 2017 07:01:00 EDT

ПЕКИН (BEIJING), 24 июня 2017 г. /PRNewswire/ -- 23 июня 2017 года компания Lilith Games в рамках международного запуска Huawei HiGame представила свій новій продукт - Art of Conquest. Благодаря этому релизу, игроки в странах Ближнего Востока и Юго-Восточной Азии смогут первыми испытать...



Globalny debiut Art of Conquest na HiGame zapewnia dostęp do gry międzynarodowym graczom

Sat, 24 Jun 2017 06:07:00 EDT

PEKIN, 24 czerwca 2017 r. /PRNewswire/ -- Dnia 23 czerwca 2017 roku producent Lilith Games opublikował grę Art of Conquest wraz z globalną premierą Huawei HiGame. Dzięki temu gracze z Bliskiego Wschodu i państw Azji Południowowschodniej będą mogli zapoznać się z grą i otrzymać wyjątkowe...



Hospital based program launched to improve outcomes for stroke patients in China to impact world's largest population

Sat, 24 Jun 2017 04:30:00 EDT

(image) BEIJING, June 24, 2017 /PRNewswire/ -- Delivering big, positive stroke outcomes for the world's largest population is the aim of the American Stroke Association (ASA) and Chinese Stroke Association (CSA) with the launch of a quality improvement program adapted from the American Heart...



Media Files:
https://mma.prnewswire.com/media/527374/Werner_Hacke____________Michelle_Bolles.jpg




This Is a Test From PR Newswire 3

Sat, 24 Jun 2017 04:30:00 EDT

(image) CLEVELAND, June 24, 2017 /PRNewswire/ -- This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test...



Media Files:
https://mma.prnewswire.com/media/527174/gradient_test.jpg




European Hematology Association: Estudio multicentro de etiqueta abierta en Fase 2 de ibrutinib

Sat, 24 Jun 2017 02:30:00 EDT

(image) MADRID, June 24, 2017 /PRNewswire/ -- European Hematology Association: Estudio multicentro de etiqueta abierta en Fase 2 de ibrutinib en injerto crónico frente a enfermedad huésped (cGVHD) tras fallo de corticoesteroides - Ibrutinib: Un nuevo tratamiento...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




European Hematology Association: covariables clínicas y biológicas de los resultados en ZUMA-1

Sat, 24 Jun 2017 02:30:00 EDT

(image) MADRID, June 24, 2017 /PRNewswire/ -- -European Hematology Association: covariables clínicas y biológicas de los resultados en ZUMA-1: un ensayo crucial de Axicabtagene Ciloleucel (axi-cel; KTE-C19) en pacientes con linfoma no Hodgkin agresivo refractario (NHL) Los resultados...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




Association européenne d'hématologie : covariables cliniques et biologiques des résultats de la ZUMA-1 : une étude pivotale portant sur l'Axicabtagene Ciloleucel (axi-cel ; KTE-C19) administrés à des patients souffrant d'un lymphome non-hodgkinien (

Sat, 24 Jun 2017 02:30:00 EDT

(image) MADRID, June 24, 2017 /PRNewswire/ -- Les résultats pour les patients souffrant d'un lymphome non hodgkinien (NHL) agressif et réfractaire sont médiocres avec les traitements actuels. L'Axicabtagene ciloleucel (axi-cel) est un traitement des cellules T à récepteur antigène chimérique...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




Association européenne d'hématologie : les hémorragies et la coagulation chez les patients âgés souffrant de la maladie thromboembolique veineuse associée au cancer : qu'est-ce qui est pire ?

Sat, 24 Jun 2017 02:30:00 EDT

(image) MADRID, June 24, 2017 /PRNewswire/ -- Le risque de caillots de sang dans les veines des jambes ou les poumons, connu comme thrombose veineuse (VTE) est plus élevé chez les patients souffrant de cancer, ainsi que le risque d'hémorragies. Tandis que le traitement aux anticoagulants...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




Association européenne d'hématologie : une étude mondiale portant sur l'efficacité et l'innocuité du CTL019 chez des patients adultes atteints du lymphome diffus à grandes cellules B récidivant ou réfractaire : une analyse intermédiaire de l'étude J

Sat, 24 Jun 2017 02:30:00 EDT

(image) MADRID, June 24, 2017 /PRNewswire/ -- Le CTL019 est composé de cellules T analogues issues du génie génétique qui expriment un récepteur antigénique chimérique (CAR). Les résultats d'une étude précédente uni-centrique menée à l'université de Pennsylvanie a montré qu'une simple...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg